查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1159381

肾生物标记的全球市场(2022年～2028年)

Renal Biomarker Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 105 Pages | 商品交期: 2-3个工作天内

价格

全球肾生物标记的市场规模在预测期间内预计将以8.7％的年复合成长率成长。推动市场成长的主要因素有老年人口中肾臟疾病发病率的迅速增加等。

本报告提供全球肾生物标记市场调查，提供市场概要，市场的推动因素与阻碍因素的分析，市场机会，各市场区隔，各地区的市场分析，主要企业的简介等系统性资讯。

目录

第1章 报告概要

第2章 市场概要与洞察

  • 调查范围
  • 分析师的洞察和目前市场趋势

第3章 竞争情形

  • 主要企业分析
  • Abbott Laboratories
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • Bayer AG
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • Novartis AG
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • Pacific Biomarkers
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • Siemens AG
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • 主要策略分析
  • COVID-19对主要企业带来的影响

第4章 市场区隔

  • 各类型
    • 诊断生物标记
    • 预后生物标记
    • 预测生物标记
    • 药效学生物标记
  • 各诊断技术
    • Elisa
    • 比色化验
    • 液体层析法-质谱分析
    • 粒子增强浊每次免疫测量
  • 各终端用户
    • 医院
    • 诊断实验室
    • 研究中心

第5章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的亚太地区
  • 全球其他地区

第6章 企业简介

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Astute Medical, Inc.
  • Bayer AG
  • Beckman Coulter Inc.
  • Bio Preventive Medicine Corp.
  • Biomerieux SA
  • Bioporto A/S
  • Enzo Life Sciences, Inc.
  • Evotec A.G.
  • Myriad Genetics Inc.
  • Novartis AG
  • Pacific Biomarkers
  • Plato Bio Pharma Inc.
  • Pliant Therapeutics, Inc.
  • R & D Systems
  • Randox Laboratories Ltd.
  • Roche Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific Inc.
Product Code: OMR2026515

Global Renal Biomarker Market Size, Share & Trends Analysis Report by Type (Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers), by Diagnostic technique (Elisa, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay), and by End-User Industry (Hospitals, Diagnostic Labs, Research Centers) Forecast (2022-2028)

The global renal biomarker market is anticipated to grow at a considerable CAGR of 8.7% during the forecast period. Kidney disease or renal disease is one of the major causes of death across the globe. The incidence of renal diseases, particularly in the geriatric population is rising rapidly owing to better life expectancy due to improvements in medical systems. Research and development activities undertaken by the biomarker manufacturers have led to the identification of novel renal biomarkers for delivering better diagnostic accuracy and for improving patient outcomes.

Global Renal biomarker is segmented based on type, diagnostic technique, and end-users. Based on type, the market is further diversified into diagnostic biomarkers, prognostic biomarkers, predictive biomarkers, and pharmacodynamic biomarkers. Based on the diagnostic technique, the market is bifurcated into Elisa, colorimetric assay, liquid chromatography-mass spectrometry, and particle-enhanced turbidimetric immunoassay. Based on the End-Users, the market is bifurcated into the hospitals, diagnostic labs, and research centers.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to hold a prominent share in the renal biomarker market during the forecast period owing to the presence of high-quality healthcare infrastructure. In addition, the prevalence rate of renal diseases is high in this region. According to the US Department of Health and Human Services, nearly 786,000 people in the United States are living with ESKD, also known as an end-stage renal disease (ESRD), with 71.0% on dialysis and 29.0% with a kidney transplant. Moreover, Europe is another significant market and holds a considerable market share in the global renal biomarker market.

The major companies serving the global renal biomarker market include Abbott Laboratories, Bayer AG, Novartis AG, Pacific Biomarkers, Siemens AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2020, Baxter International Inc. announced a distribution agreement with Biomerieux for the NEPHROCLEAR CCL14 diagnostic test in Europe and US.

Research Methodology

The market study of the global renal biomarker market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Renal biomarker Market Research and Analysis by Type.

2. Global Renal biomarker Market Research and Analysis by Diagnostic Technique.

3. Global Renal biomarker Market Research and Analysis by End-Users.

The Report Covers:

  • Comprehensive Research Methodology of the global renal biomarker market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global pharmaceutical filtration market.
  • Insights about market determinants that are stimulating the global renal biomarker market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Renal Biomarker Market
  • Recovery Scenario of Global Renal Biomarker Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bayer AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Novartis AG
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Pacific Biomarkers
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Siemens AG
    • 3.6.1. Overview
    • 3.6.2. Financial Analysis
    • 3.6.3. SWOT Analysis
    • 3.6.4. Recent Developments
  • 3.7. Key Strategy Analysis
  • 3.8. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Renal Biomarker Market by Type
    • 4.1.1. Diagnostic Biomarkers
    • 4.1.2. Prognostic Biomarkers
    • 4.1.3. Predictive Biomarkers
    • 4.1.4. Pharmacodynamic Biomarkers
  • 4.2. Global Renal Biomarker Market by Diagnostic Technique
    • 4.2.1. Elisa
    • 4.2.2. Colorimetric Assay
    • 4.2.3. Liquid Chromatography-Mass Spectrometry
    • 4.2.4. Particle-Enhanced Turbidimetric Immunoassay
  • 4.3. Global Renal Biomarker Market by End-Users
    • 4.3.1. Hospitals
    • 4.3.2. Diagnostic Labs
    • 4.3.3. Research Centres

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profile

  • 6.1. Abbott Laboratories
  • 6.2. Astellas Pharma Inc.
  • 6.3. Astute Medical, Inc.
  • 6.4. Bayer AG
  • 6.5. Beckman Coulter Inc.
  • 6.6. Bio Preventive Medicine Corp.
  • 6.7. Biomerieux SA
  • 6.8. Bioporto A/S
  • 6.9. Enzo Life Sciences, Inc.
  • 6.10. Evotec A.G.
  • 6.11. Myriad Genetics Inc.
  • 6.12. Novartis AG
  • 6.13. Pacific Biomarkers
  • 6.14. Plato Bio Pharma Inc.
  • 6.15. Pliant Therapeutics, Inc.
  • 6.16. R & D Systems
  • 6.17. Randox Laboratories Ltd.
  • 6.18. Roche Diagnostics
  • 6.19. Siemens AG
  • 6.20. Thermo Fisher Scientific Inc.

LIST OF TABLES

  • 1. GLOBAL RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL DIAGNOSTIC BIOMARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL PROGNOSTIC BIOMARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL PREDICTIVE BIOMARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL PHARMACODYNAMIC BIOMARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
  • 7. GLOBAL ELISA RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL COLORIMETRIC ASSAY RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL INFLAMMATORY HEART DISEASEMARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
  • 12. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL DIAGNOSTIC LABS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL RESEARCH CENTRES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 16. NORTH AMERICAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
  • 20. EUROPEAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 21. EUROPEAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 22. EUROPEAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
  • 23. EUROPEAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)
  • 24. ASIA-PACIFIC RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 25. ASIA-PACIFIC RENAL BIOMARKE RMARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 26. ASIA-PACIFIC RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 29. REST OF THE WORLD RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL RENAL BIOMARKER MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL RENAL BIOMARKER MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL RENAL BIOMARKER MARKET, 2022-2028 (%)
  • 4. GLOBAL RENAL BIOMARKER MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL DIAGNOSTIC BIOMARKERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL PROGNOSTIC BIOMARKERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL PREDICTIVE BIOMARKERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL PHARMACODYNAMIC BIOMARKERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL RENAL BIOMARKER MARKET SHARE BY DIAGNOSTIC TECHNIQUE, 2021 VS 2028 (%)
  • 10. GLOBAL ELISA RENAL BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL COLORIMETRIC ASSAY RENAL BIOMARKERMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY RENAL BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY RENAL BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL RENAL BIOMARKER MARKET SHARE BY END-USERS, 2021 VS 2028 (%)
  • 15. GLOBAL HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL DIAGNOSTIC LABS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. GLOBAL RESEARCH CENTRES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 18. GLOBAL RENAL BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 19. US RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. CANADA RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. UK RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. FRANCE RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. GERMANY RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. ITALY RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. SPAIN RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. REST OF EUROPE RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. INDIA RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. CHINA RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. JAPAN RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. SOUTH KOREA RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. REST OF ASIA-PACIFIC RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)